title: 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation.
abstract: A tissue field of somatic genetic alterations precede the histopathological phenotypic changes of carcinoma. Loss of Heterozygosity (LOH) at the sites of known or putative tumor suppressor genes is a common genetic abnormality detected in precancerous conditions. These genomic changes could be of potential use in the diagnosis and prognosis of pre-malignant laryngeal lesions. Recently the concept of laryngeal intraepithelial neoplasia (LIN) was introduced. To evaluate patients with an increased risk of developing invasive laryngeal carcinoma via a dysplasia-carcinoma progression we investigated 102 microdissected cell populations. Cell populations were procured from 15 laryngectomy specimens with different peritumoral histological changes adjacent to the squamous cell carcinoma cells and 15 laryngeal endoscopic biopsies with no evidence of malignant transformation in a 6-10-year follow-up period. Histological diagnoses were subdivided into keratosis without dysplasia (KWD), with mild dysplasia (LIN 1), with moderate dysplasia (LIN 2), and with severe dysplasia or carcinoma in situ (LIN 3). Microsatellite analysis was performed with the aim of studying LOH of 5q21 (APC), 9p21 (p16), 3p21 and 17p13 (p53) chromosomal regions. Frequent allelic losses were found in carcinoma cells at p53 (54%), p16 (66%), 3p21(87%) and 5q21(58%). Identical LOH patterns were determined in 100% of the LIN3 peritumoral cells, 60% of LIN2, 50% of LIN 1 and 25% of KWD. In contrast, histologically normal mucosae, KWD and LIN1 lesions without malignant progression showed no allelic loss. These results show that dysplasia correlates with LOH at 3p21, 5q21, 9p21 and 17p13 in early laryngeal carcinogenesis. These genomic changes in pre-malignant laryngeal lesions could be of potential use as markers for cancer risk assessment.
authors.affiliation: Department of Pathology, San Carlos Clinic Hospital, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Sanz-Ortega
authors.forename: C
authors.initials: C
authors.lastname: Valor
authors.forename: M C
authors.initials: MC
authors.lastname: Saez
authors.forename: L
authors.initials: L
authors.lastname: Ortega
authors.forename: E
authors.initials: E
authors.lastname: Sierra
authors.forename: J
authors.initials: J
authors.lastname: Poch
authors.forename: S
authors.initials: S
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: Sanz-Esponera
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology*; D002872:Chromosome Deletion; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D006579:Heterozygote; D006801:Humans; D007822:Laryngeal Neoplasms / Q000235:genetics* / Q000473:pathology*; D007825:Laryngectomy; D007830:Larynx / Q000473:pathology*; D008875:Middle Aged; D016612:Paraffin Embedding; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016707:Tissue Fixation
chemical_list: D004273:DNA, Neoplasm